Fig. 2From: An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetesScatter plots of changes in HbA1c and body weight (a), HbA1c and ESS (b) and body weight and ESS (c) from baseline to month 3 of treatment with liraglutideBack to article page